30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Oldtech Inc (EYET)

Track

Stock chart
Ticker: EYET Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
CHANEY PAUL G
Chief Operating Officer
2 sales — total 1,691,643 USD
Sale 4 Nov 2005
Value US$119,870.33 | Price 54.46 | Shares 30,807
Sale 4 Nov 2005
Value US$4,401,505.99 | Price 374.87 | Shares 55,106
Sale 4 Nov 2005
Value US$3,084,417.14 | Price 137.12 | Shares 93,853
Sale 3 Nov 2005
Value US$925,575.00 | Price 17.63 | Shares 52,500
Sale 3 Nov 2005
Value US$1,875,741.92 | Price 17.68 | Shares 106,094
Planned sale 1 Aug 2005
Value US$20,997.50 | Price 11.35 | Shares 1,850
Planned sale 1 Aug 2005
Value US$20,997.50 | Price 11.35 | Shares 1,850
Planned sale 1 Aug 2005
Value US$31,724.00 | Price 11.33 | Shares 2,800
Planned sale 1 Aug 2005
Value US$60,438.75 | Price 11.35 | Shares 5,325
Planned sale 1 Aug 2005
Value US$176,748.00 | Price 11.33 | Shares 15,600
Planned sale 1 Jul 2005
Value US$195,936.00 | Price 12.56 | Shares 15,600
Planned sale 1 Jul 2005
Value US$23,291.50 | Price 12.59 | Shares 1,850
Planned sale 1 Jul 2005
Value US$23,291.50 | Price 12.59 | Shares 1,850
Planned sale 1 Jul 2005
Value US$67,041.75 | Price 12.59 | Shares 5,325
Planned sale 1 Jul 2005
Value US$35,504.00 | Price 12.68 | Shares 2,800
Planned sale 1 Jun 2005
Value US$202,020.00 | Price 12.95 | Shares 15,600
Planned sale 1 Jun 2005
Value US$36,344.00 | Price 12.98 | Shares 2,800
Planned sale 1 Jun 2005
Value US$23,939.00 | Price 12.94 | Shares 1,850
Planned sale 1 Jun 2005
Value US$23,939.00 | Price 12.94 | Shares 1,850
Planned sale 1 Jun 2005
Value US$68,958.75 | Price 12.95 | Shares 5,325
Planned sale 2 May 2005
Value US$1,186,500.00 | Price 23.73 | Shares 50,000
Planned sale 1 Apr 2005
Value US$1,375,000.00 | Price 27.50 | Shares 50,000
Planned sale 1 Mar 2005
Value US$1,639,000.00 | Price 32.78 | Shares 50,000
Planned sale 1 Feb 2005
Value US$3,597,000.00 | Price 35.97 | Shares 100,000
Sale 1 Feb 2005
Value US$238,590.00 | Price 36.15 | Shares 6,600
Planned sale 1 Feb 2005
Value US$721,400.00 | Price 36.07 | Shares 20,000
Sale 31 Jan 2005
Value US$145,800.00 | Price 36.45 | Shares 4,000
Sale 19 Jan 2005
Value US$1,991,500.00 | Price 39.83 | Shares 50,000
Planned sale 4 Jan 2005
Value US$356,811.40 | Price 43.45 | Shares 8,212
Planned sale 3 Jan 2005
Value US$894,200.00 | Price 44.71 | Shares 20,000
Planned sale 3 Jan 2005
Value US$1,788,000.00 | Price 44.70 | Shares 40,000
Planned sale 3 Jan 2005
Value US$371,264.52 | Price 45.21 | Shares 8,212
Planned sale 31 Dec 2004
Value US$180,760.00 | Price 45.19 | Shares 4,000
Planned sale 21 Dec 2004
Value US$1,675,200.00 | Price 41.88 | Shares 40,000
Planned sale 20 Dec 2004
Value US$871,600.00 | Price 43.58 | Shares 20,000
Sale 20 Dec 2004
Value US$916,225.92 | Price 43.58 | Shares 21,024
Sale 20 Dec 2004
Value US$129,694.08 | Price 43.58 | Shares 2,976
Sale 20 Dec 2004
Value US$348,640.00 | Price 43.58 | Shares 8,000
Planned sale 30 Nov 2004
Value US$161,200.00 | Price 40.30 | Shares 4,000
Sale 17 Nov 2004
Value US$47,275.45 | Price 45.41 | Shares 1,041
Sale 17 Nov 2004
Value US$624,435.62 | Price 45.41 | Shares 13,750
Planned sale 16 Nov 2004
Value US$225,850.00 | Price 45.17 | Shares 5,000
Sale 29 Oct 2004
Value US$0.00 | Price 0.00 | Shares 4,000
Sale 28 Oct 2004
Value US$41,260,000.00 | Price 41.26 | Shares 1,000,000
Sale 28 Oct 2004
Value US$41,260,000.00 | Price 41.26 | Shares 1,000,000
Sale 15 Oct 2004
Value US$1,407,575.00 | Price 43.31 | Shares 32,500
Sale 14 Oct 2004
Value US$105,225.00 | Price 42.09 | Shares 2,500
Sale 14 Oct 2004
Value US$420,900.00 | Price 42.09 | Shares 10,000
Sale 14 Oct 2004
Value US$309,375.00 | Price 41.25 | Shares 7,500
Sale 30 Sep 2004
Value US$498,300.00 | Price 33.22 | Shares 15,000
Sale 31 Aug 2004
Value US$524,400.00 | Price 34.96 | Shares 15,000
Sale 2 Jun 2004
Value US$31,193,585.50 | Price 38.50 | Shares 810,223
Sale 2 Jun 2004
Value US$31,193,585.50 | Price 38.50 | Shares 810,223
Sale 26 May 2004
Value US$371,533.50 | Price 36.50 | Shares 10,179
Sale 26 May 2004
Value US$12,408,941.50 | Price 36.50 | Shares 339,971
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2005-11-07 2005-11-04 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
30,807 -30.4%
54.46
US$119,870 		30,807 -30.4% 54.46 US$119,870
2005-11-07 2005-11-04 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
55,106 -19.9%
374.87
US$4,401,506 		55,106 -19.9% 374.87 US$4,401,506
2005-11-07 2005-11-04 S Sale SBLENDORIO GLENN

Chief Financial Officer

Officer
93,853 +36.1%
137.12
US$3,084,417 		93,853 +36.1% 137.12 US$3,084,417
2005-11-07 2005-11-03 S Sale SBLENDORIO GLENN

Chief Financial Officer

Officer
52,500 -54.9%
17.63
US$925,575 		52,500 -54.9% 17.63 US$925,575
2005-11-07 2005-11-03 S Sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
106,094 -49.1%
17.68
US$1,875,742 		106,094 -49.1% 17.68 US$1,875,742
2005-08-01 2005-08-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
11.35
US$20,998 		1,850 -4.1% 11.35 US$20,998
2005-08-01 2005-08-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
11.35
US$20,998 		1,850 -4.1% 11.35 US$20,998
2005-08-01 2005-08-01 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
2,800 -8.4%
11.33
US$31,724 		2,800 -8.4% 11.33 US$31,724
2005-08-01 2005-08-01 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
5,325 -4.6%
11.35
US$60,439 		5,325 -4.6% 11.35 US$60,439
2005-08-01 2005-08-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
15,600 -1.3%
11.33
US$176,748 		15,600 -1.3% 11.33 US$176,748
2005-07-01 2005-07-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
15,600 -1.3%
12.56
US$195,936 		15,600 -1.3% 12.56 US$195,936
2005-07-01 2005-07-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
12.59
US$23,292 		1,850 -4.1% 12.59 US$23,292
2005-07-01 2005-07-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -4.1%
12.59
US$23,292 		1,850 -4.1% 12.59 US$23,292
2005-07-01 2005-07-01 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
5,325 -4.4%
12.59
US$67,042 		5,325 -4.4% 12.59 US$67,042
2005-07-01 2005-07-01 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
2,800 -8.4%
12.68
US$35,504 		2,800 -8.4% 12.68 US$35,504
2005-06-03 2005-06-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
15,600 -1.4%
12.95
US$202,020 		15,600 -1.4% 12.95 US$202,020
2005-06-03 2005-06-01 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
2,800 -82.5%
12.98
US$36,344 		2,800 -82.5% 12.98 US$36,344
2005-06-03 2005-06-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -75.7%
12.94
US$23,939 		1,850 -75.7% 12.94 US$23,939
2005-06-03 2005-06-01 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
1,850 -75.7%
12.94
US$23,939 		1,850 -75.7% 12.94 US$23,939
2005-06-03 2005-06-01 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
5,325 -15.9%
12.95
US$68,959 		5,325 -15.9% 12.95 US$68,959
2005-05-03 2005-05-02 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -22.3%
23.73
US$1,186,500 		50,000 -22.3% 23.73 US$1,186,500
2005-04-01 2005-04-01 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -18.2%
27.50
US$1,375,000 		50,000 -18.2% 27.50 US$1,375,000
2005-03-01 2005-03-01 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -15.4%
32.78
US$1,639,000 		50,000 -15.4% 32.78 US$1,639,000
2005-02-03 2005-02-01 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
100,000 -8.4%
35.97
US$3,597,000 		100,000 -8.4% 35.97 US$3,597,000
2005-02-02 2005-02-01 S Sale GLICK MARTY Non-Executive Director
6,600 -1.2%
36.15
US$238,590 		6,600 -1.2% 36.15 US$238,590
2005-02-02 2005-02-01 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
20,000 -5.8%
36.07
US$721,400 		20,000 -5.8% 36.07 US$721,400
2005-02-02 2005-01-31 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000 -100.0%
36.45
US$145,800 		4,000 -100.0% 36.45 US$145,800
2005-01-20 2005-01-19 S Sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
50,000 -12.7%
39.83
US$1,991,500 		50,000 -12.7% 39.83 US$1,991,500
2005-01-05 2005-01-04 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
8,212 -29.8%
43.45
US$356,811 		8,212 -29.8% 43.45 US$356,811
2005-01-13 2005-01-03 PlS Planned sale PATEL SAMIR CHANDRAKANT

Chief Commercial & Medical

Executive Director
20,000 -4.8%
44.71
US$894,200 		20,000 -4.8% 44.71 US$894,200
2005-01-13 2005-01-03 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
40,000 -3.3%
44.70
US$1,788,000 		40,000 -3.3% 44.70 US$1,788,000
2005-01-05 2005-01-03 PlS Planned sale ADAMIS ANTHONY P

Chief Scientific Officer

Officer
8,212 -29.8%
45.21
US$371,265 		8,212 -29.8% 45.21 US$371,265
2005-01-04 2004-12-31 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000 -100.0%
45.19
US$180,760 		4,000 -100.0% 45.19 US$180,760
2004-12-21 2004-12-21 PlS Planned sale GUYER DAVID R

Chief Executive Officer

Executive Director
40,000 -3.2%
41.88
US$1,675,200 		40,000 -3.2% 41.88 US$1,675,200
2004-12-21 2004-12-20 PlS Planned sale PATEL SAMIR CHANDRAKANT Non-Executive Director
20,000 -4.6%
43.58
US$871,600 		20,000 -4.6% 43.58 US$871,600
2004-12-21 2004-12-20 S Sale ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel

Officer
21,024 -98.4%
43.58
US$916,226 		21,024 -98.4% 43.58 US$916,226
2004-12-21 2004-12-20 S Sale ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel

Officer
2,976 -89.9%
43.58
US$129,694 		2,976 -89.9% 43.58 US$129,694
2004-12-21 2004-12-20 S Sale ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel

Officer
8,000 -96.0%
43.58
US$348,640 		8,000 -96.0% 43.58 US$348,640
2004-11-30 2004-11-30 PlS Planned sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000 -100.0%
40.30
US$161,200 		4,000 -100.0% 40.30 US$161,200
2004-11-17 2004-11-17 S Sale PENHOET EDWARD

No longer a Director
1,041 -28.6%
45.41
US$47,275 		1,041 -28.6% 45.41 US$47,275
2004-11-17 2004-11-17 S Sale PENHOET EDWARD

No longer a Director
13,750 -79.0%
45.41
US$624,436 		13,750 -79.0% 45.41 US$624,436
2004-11-17 2004-11-16 PlS Planned sale SBLENDORIO GLENN

Chief Financial Officer

Officer
5,000 -100.0%
45.17
US$225,850 		5,000 -100.0% 45.17 US$225,850
2004-11-01 2004-10-29 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
4,000
0.00
US$0 		4,000 0.00 US$0
2004-10-29 2004-10-28 S Sale
WICKER DAMION E MD
1,000,000 -30.9%
41.26
US$41,260,000 		1,000,000 -30.9% 41.26 US$41,260,000
2004-10-29 2004-10-28 S Sale
JP MORGAN PARTNERS BHCA LP
Large shareholder
1,000,000 -30.9%
41.26
US$41,260,000 		1,000,000 -30.9% 41.26 US$41,260,000
2004-10-18 2004-10-15 S Sale
ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel
32,500 -79.6%
43.31
US$1,407,575 		32,500 -79.6% 43.31 US$1,407,575
2004-10-18 2004-10-14 S Sale
ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel
2,500 -23.1%
42.09
US$105,225 		2,500 -23.1% 42.09 US$105,225
2004-10-18 2004-10-14 S Sale
ALTSCHULER DOUGLAS H

Sr VP, Legal, General Counsel
10,000 -54.5%
42.09
US$420,900 		10,000 -54.5% 42.09 US$420,900
2004-10-15 2004-10-14 S Sale
0.6
SBLENDORIO GLENN

Chief Financial Officer
7,500 -100.0%
41.25
US$309,375 		7,500 -100.0% 41.25 US$309,375
2004-10-01 2004-09-30 S Sale
CHANEY PAUL G

Chief Operating Officer
15,000 -100.0%
33.22
US$498,300 		15,000 -100.0% 33.22 US$498,300
2004-08-31 2004-08-31 S Sale CHANEY PAUL G

Chief Operating Officer

Officer
15,000 -100.0%
34.96
US$524,400 		15,000 -100.0% 34.96 US$524,400
2004-06-04 2004-06-02 S Sale WICKER DAMION E MD Non-Executive Director
810,223 -20.0%
38.50
US$31,193,586 		810,223 -20.0% 38.50 US$31,193,586
2004-06-04 2004-06-02 S Sale JP MORGAN PARTNERS BHCA LP Large shareholder
810,223 -20.0%
38.50
US$31,193,586 		810,223 -20.0% 38.50 US$31,193,586
2004-06-02 2004-05-26 S Sale PENHOET EDWARD Non-Executive Director
10,179 -27.2%
36.50
US$371,534 		10,179 -27.2% 36.50 US$371,534
2004-06-02 2004-05-26 S Sale PENHOET EDWARD Non-Executive Director
339,971 -27.2%
36.50
US$12,408,942 		339,971 -27.2% 36.50 US$12,408,942
Explore more

More insider trading research around Oldtech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America